As of June 2024 Regulus Therapeutics has a market cap of $0.14 Billion. This makes Regulus Therapeutics the world's 7195th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.14 B | 479.16% |
2023 | $25.88 M | 12.2% |
2022 | $23.07 M | -49.82% |
2021 | $45.98 M | -46.37% |
2020 | $85.73 M | 358.29% |
2019 | $18.7 M | 127.96% |
2018 | $8.2 M | -92.41% |
2017 | $0.10 B | -9.21% |
2016 | $0.11 B | -74.07% |
2015 | $0.45 B | -41.5% |
2014 | $0.78 B | 154.23% |
2013 | $0.30 B | 36.8% |
2012 | $0.22 B |
On Jun 1st, 2024 the market cap of Regulus Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Sanofi SNY | $122.54 B | 81,642.00% | ๐ซ๐ท France |
Biogen BIIB | $32.75 B | 21,745.83% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $83.29 B | 55,459.81% | ๐บ๐ธ USA |
AstraZeneca AZN | $241.89 B | 161,255.16% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $93.92 B | 62,550.33% | ๐ฌ๐ง UK |
Sangamo Therapeutics
SGMO | $0.11 B | -21.88% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | $2.97 B | 1,886.23% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $18.77 B | 12,423.74% | ๐บ๐ธ USA |